Sep 18, 2015 - Allergan (AGN) and Gedeon Richter Plc. announced that the FDA has approved Vraylar for the treatment of bipolar I disorder and schizophrenia in adults.
Sep 11, 2015 - Apricus Biosciences' (APRI) shares gained 7.7% after the company regained the U.S. development and commercialization rights to Vitaros from Allergan.
Sep 11, 2015 - Apricus Biosciences (APRI) was a big mover last session with its shares rising roughly 8% on the day.
Sep 04, 2015 - Allergan plc (AGN) announced that it has entered into an agreement to acquire AqueSys, Inc.
Sep 03, 2015 - AstraZeneca (AZN) signs up with Daiichi Sankyo for FluMist Quadrivalent in Japan; reports positive phase III data on antibiotic drug CAZ-AVI.
Sep 01, 2015 - Allergan (AGN) acquires central nervous system focused company, Naurex, to boost mental disorder portfolio.
Sep 01, 2015 - Benchmarks ended in the red on Monday after Federal Vice Chairman Stanley Fischer’s comments on Saturday left possibilities of September rate hike wide open
Aug 31, 2015 - Benchmarks ended Friday’s choppy trading session little changed amid another surge in oil prices and Fed official’s comment on the timing of a rate hike
Aug 27, 2015 - Benchmarks scored a multi-record percentage gain on Wednesday following strong durable-goods report and comments from a Fed official that a September rate hike seems inappropriate
Aug 26, 2015 - Eli Lilly and Company announced that it has received a favorable ruling in a lawsuit related to the infringement of vitamin regimen patent for Alimta.